We are live on
!
Find out more
First Manhattan Portfolio holdings
AUM
$36.1B
1-Year Est. Return
11.5%
This Fund
S&P 500
This Quarter
Est. Return
+9.64%
1 Year Est. Return
+11.5%
3 Year Est. Return
+74.65%
5 Year Est. Return
+103.66%
10 Year Est. Return
+354.63%
AUM
$27.3B
AUM Growth
+$1.22B
(+4.7%)
Cap. Flow
-$932M
Cap. Flow
% of AUM
-3.41%
Top 10 Holdings %
Top 10 Hldgs %
60.57%
Holding
1,588
New
70
Increased
176
Reduced
495
Closed
161
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$128M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$67.4M |
| 3 |
XIFR
XPLR Infrastructure LP
XIFR
|
+$63.8M |
| 4 |
UnitedHealth
UNH
|
+$57.4M |
| 5 |
Danaher
DHR
|
+$24.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$760M |
| 2 |
Amazon
AMZN
|
+$68.5M |
| 3 |
AbbVie
ABBV
|
+$54.2M |
| 4 |
PPLI
People Inc
PPLI
|
+$36.8M |
| 5 |
PNC Financial Services
PNC
|
+$29.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 44.09% |
| 2 | Technology | 18.28% |
| 3 | Healthcare | 10.34% |
| 4 | Consumer Discretionary | 7.89% |
| 5 | Communication Services | 5.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
676
Ironwood Pharmaceuticals
IRWD
$611M
| $159K | ﹤0.01% |
14,925
| – | – |
|
677
Mettler-Toledo International
MTD
$26.8B
| $159K | ﹤0.01% |
121
| – | – |
|
678
Southern Company
SO
$110B
| $158K | ﹤0.01% |
2,244
-734
| -25% | -$52.6K |
|
679
BancFirst
BANF
$3.92B
| $156K | ﹤0.01% |
1,700
| – | – |
|
680
iShares Expanded Tech-Software Sector ETF
IGV
$13B
| $156K | ﹤0.01% |
2,250
+375
| +20% | +$23.5K |
|
681
GXO Logistics
GXO
$6.06B
| $155K | ﹤0.01% |
2,463
-548
| -18% | -$30.7K |
|
682
Teva Pharmaceuticals
TEVA
$35.9B
| $154K | ﹤0.01% |
20,500
| – | – |
|
|
UCB
683
United Community Banks
UCB
$4.22B
| $154K | ﹤0.01% |
6,167
-33
| -0.5% | -$819 |
|
684
State Street
STT
$50.9B
| $151K | ﹤0.01% |
2,069
-1,000
| -33% | -$71.9K |
|
685
Vanguard Russell 2000 Growth ETF
VTWG
$1.47B
| $150K | ﹤0.01% |
850
| – | – |
|
686
Tetra Tech
TTEK
$8.23B
| $150K | ﹤0.01% |
4,570
| – | – |
|
687
Vanguard Russell 2000 Value ETF
VTWV
$1.29B
| $148K | ﹤0.01% |
1,200
| – | – |
|
688
Canadian National Railway
CNI
$78.3B
| $147K | ﹤0.01% |
1,213
| – | – |
|
689
Ducommun
DCO
$2.68B
| $146K | ﹤0.01% |
3,350
-700
| -17% | -$33K |
|
690
Regeneron Pharmaceuticals
REGN
$68.8B
| $145K | ﹤0.01% |
202
| – | – |
|
691
Gartner
IT
$9.41B
| $145K | ﹤0.01% |
414
-26
| -6% | -$8.47K |
|
692
Cognizant
CTSH
$21.5B
| $144K | ﹤0.01% |
2,206
+170
| +8% | +$10.5K |
|
|
TGB
693
Trekor Metals
TGB
$2.56B
| $143K | ﹤0.01% |
100,000
| – | – |
|
|
XOMA
694
DELISTED
Xoma
XOMA
| $142K | ﹤0.01% |
7,500
| – | – |
|
695
United-Guardian
UG
$35M
| $141K | ﹤0.01% |
17,062
| – | – |
|
696
Cerus
CERS
$587M
| $140K | ﹤0.01% |
57,000
-5,000
| -8% | -$11.9K |
|
697
Five Point Holdings
FPH
$379M
| $137K | ﹤0.01% |
47,500
| – | – |
|
698
Equinix
EQIX
$107B
| $137K | ﹤0.01% |
175
-50
| -22% | -$36.6K |
|
699
Dover
DOV
$27.2B
| $136K | ﹤0.01% |
924
| – | – |
|
|
LSI
700
DELISTED
Life Storage, Inc.
LSI
| $136K | ﹤0.01% |
1,025
| – | – |
|
Similar funds
SAM
First Manhattan's Q2 2023 Portfolio in Review
As of Q2 2023, First Manhattan held 1,588 positions worth $27.3B, up 4.7% from $26.1B the previous quarter. Its ten largest holdings account for 61% of the portfolio.
First Manhattan withdrew a net $932M in Q2 2023, closing 161 positions and reducing 495 holdings. Its most notable exit was Enanta Pharmaceuticals, an estimated $10.7M position sold in full.
By sector, the portfolio is most concentrated in Financials at 44% of assets, down from 45% a quarter earlier, followed by Technology and Healthcare.
Against the trend, First Manhattan opened a new position in Mersana Therapeutics worth $1.87M.
- First Manhattan's largest Q2 2023 buy was Mersana Therapeutics: 22,784 shares worth $1.87M.
- First Manhattan added most to Thermo Fisher Scientific in Q2 2023, an estimated $128M increase.
- First Manhattan's biggest Q2 2023 reduction was Berkshire Hathaway Class A, cutting an estimated $760M.
- First Manhattan fully exited Enanta Pharmaceuticals in Q2 2023, selling an estimated $10.7M.
- First Manhattan's ten largest holdings make up 61% of its $27.3B portfolio in Q2 2023.
- First Manhattan opened 70 new positions and closed 161 in Q2 2023.
- First Manhattan's portfolio value rose 4.7% quarter-over-quarter to $27.3B.
Based on First Manhattan's 13F filing for Q2 2023, filed 14 Aug 2023.